Summary
This Mendelian randomization study examined causal relationships between metabolic factors and lung cancer risk, analysing 29,266 cases and 56,450 controls across three major histological subtypes. The analysis identified a causal effect of body mass index on squamous cell (OR 1.20) and small cell carcinoma (OR 1.52) but not adenocarcinoma, whilst providing novel evidence that genetic obesity susceptibility increases smoking intensity. The findings also support causal roles for elevated fasting insulin and reduced low-density lipoprotein cholesterol in lung cancer aetiology.
UK applicability
The findings may inform UK public health strategies addressing obesity and metabolic syndrome as modifiable risk factors for certain lung cancer subtypes, particularly in prevention and smoking cessation programmes. However, applicability depends on whether the genetic architecture and metabolic profiles identified in this international cohort are representative of UK populations.
Key measures
Odds ratios and 95% confidence intervals for lung cancer risk per standard deviation increase in BMI (4.6 kg/m²), low-density lipoprotein cholesterol (38 mg/dl), and fasting insulin (44.4 pmol/l); cigarette consumption per day; histological subtype stratification (adenocarcinoma, squamous cell, small cell)
Outcomes reported
The study evaluated causal relationships between genetic instruments for metabolic risk factors (BMI, cholesterol, fasting insulin) and lung cancer risk across three histological subtypes using Mendelian randomization analysis in 29,266 cases and 56,450 controls. It measured odds ratios for lung cancer subtypes per standard deviation increase in each metabolic factor.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.